- Open Access
Erratum to: Dual HER2 blockade: preclinical and clinical data
Breast Cancer Research volume 16, Article number: 468 (2014)
- The original article was published in Breast Cancer Research 2014 16:419
After publication of our review , we noted errors to the legend of Figure 1B, C. The ado-trastuzumab-emtansine concentration should be 1 μg/ml instead of 1 mg/ml. The trastuzumab concentration should be 10 μg/ml instead of 10 mg/ml. The lapatinib concentration should be 10 μM instead of 10 mM (Please see Figure 1, a corrected version of the original Figure 1).
Patel TA, Dave B, Rodriguez AA, Chang JC, Perez EA, Colon-Otero G: Dual HER2 blockade: preclinical and clinical data. Breast Cancer Res. 2014, 16: 419-10.1186/s13058-014-0419-5.
The online version of the original article can be found at 10.1186/s13058-014-0419-5
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Patel, T.A., Dave, B., Rodriguez, A.A. et al. Erratum to: Dual HER2 blockade: preclinical and clinical data. Breast Cancer Res 16, 468 (2014). https://doi.org/10.1186/s13058-014-0468-9